Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 16BAYER HEALTHCARE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Patent Expiration Date : 2036-01-28

DAROLUTAMIDE

US Patent Number : 10835515

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212099

Patent Use Code : U-4210

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-01-28

Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Patent Expiration Date : 2036-01-28

DAROLUTAMIDE

US Patent Number : 10835515

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212099

Patent Use Code : U-4208

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-01-28

Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Patent Expiration Date : 2036-01-28

DAROLUTAMIDE

US Patent Number : 10835515

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212099

Patent Use Code : U-4209

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-01-28

Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Patent Expiration Date : 2033-03-25

DAROLUTAMIDE

US Patent Number : 8975254

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212099

Patent Use Code : U-4208

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-03-25

Company Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Patent Expiration Date : 2033-03-25

DAROLUTAMIDE

US Patent Number : 8975254

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212099

Patent Use Code : U-4210

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-03-25

Company Banner

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Patent Expiration Date : 2033-03-25

DAROLUTAMIDE

US Patent Number : 8975254

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212099

Patent Use Code : U-4209

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-03-25

Company Banner

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Patent Expiration Date : 2030-10-27

DAROLUTAMIDE

US Patent Number : 9657003

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212099

Patent Use Code : U-4209

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-10-27

Company Banner

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Patent Expiration Date : 2030-10-27

DAROLUTAMIDE

US Patent Number : 9657003

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212099

Patent Use Code : U-4208

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-10-27

Company Banner

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Patent Expiration Date : 2030-10-27

DAROLUTAMIDE

US Patent Number : 9657003

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 212099

Patent Use Code : U-4210

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-10-27

Company Banner

10

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Patent Expiration Date : 2036-01-28

DAROLUTAMIDE

US Patent Number : 10835515

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212099

Patent Use Code : U-2605

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-01-28

Company Banner